Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Core Insights - Vanda Pharmaceuticals Inc. received FDA approval for NEREUS (tradipitant), an oral neurokinin-1 receptor antagonist, aimed at preventing motion-induced vomiting in adults, leading to a 17.5% increase in share price to $8.26 in pre-market trading [1] Gainers - Aimei Health Technology Co Ltd surged 61.6% to $133.00 in pre-market trading after an 89% increase on Tuesday [4] - Anghami Inc rose 49.1% to $3.46 following the release of its six-month results [4] - Oriental Rise Holdings Ltd increased by 42.6% to $1.74 after announcing a nonbinding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group Co. Ltd. [4] - Northann Corp rose 39.7% to $0.27 after a 15% dip on Tuesday [4] - Inspire Veterinary Partners Inc gained 35.4% to $0.068 after an 18% increase on Tuesday [4] - iSpecimen Inc rose 29.1% to $0.38 after announcing a $5.5 million private placement [4] - Direct Digital Holdings Inc gained 28.4% to $0.077 after a 12% increase on Tuesday [4] - A SPAC III Acquisition Corp rose 25% to $34.84 [4] - LI Bang International Corporation Inc gained 24.5% to $0.66 after a 13% decline on Tuesday [4] Losers - Profusa Inc fell 14.5% to $0.10 after announcing debt restructuring and potential shareholder dilution [4] - ATIF Holdings Ltd declined 12.1% to $5.21 after filing for a mixed shelf of up to $500 million [4] - Fitell Corp fell 12.1% to $0.60 [4] - Brenmiller Energy Ltd dipped 11.8% to $0.54 after a 24% decline on Tuesday [4] - Akari Therapeutics PLC fell 11.1% to $0.24 [4] - Intercont (Cayman) Ltd declined 8.7% to $0.20 after a 4% dip on Tuesday [4] - Antelope Enterprise Holdings Ltd dipped 8.3% to $2.00 after a 92% gain on Tuesday [4] - Milestone Scientific Inc fell 8.6% to $0.25 after a 5% dip on Tuesday [4] - Jefferson Capital Inc shares dipped 7.2% to $21.08 [4] - Cybin Inc tumbled 6.6% to $8.00 after launching a $100 million at-the-market equity program [4]